Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | GSK2256098 |
| Trade Name | |
| Synonyms | GSK-2256098|GSK 2256098 |
| Drug Descriptions |
GSK2256098 is an inhibitor of focal adhesion kinase (FAK), which blocks integrin signaling and therefore, has antitumor activities (PMID: 21787277, PMID: 30992546). |
| DrugClasses | FAK inhibitor 16 |
| CAS Registry Number | 1224887-10-8 |
| NCIT ID | C88346 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Cisplatin + GSK2256098 | Cisplatin GSK2256098 | 0 | 0 |
| GSK2256098 | GSK2256098 | 2 | 1 |
| GSK2256098 + Paclitaxel | GSK2256098 Paclitaxel | 1 | 0 |
| GSK2256098 + Topotecan | GSK2256098 Topotecan | 1 | 0 |
| GSK2256098 + Trametinib | GSK2256098 Trametinib | 0 | 1 |